Different Storing and Processing Conditions of Human Lymphocytes do not Alter P-Glycoprotein Rhodamine 123 Efflux

dc.contributor.authorChiva Blanch, Gemma
dc.contributor.authorGiménez Bonafé, Pepita
dc.contributor.authorLlaudó Vallmajor, Inés
dc.contributor.authorTorras Ambròs, Joan
dc.contributor.authorCruzado, Josep Ma.
dc.contributor.authorPetriz, Jordi
dc.contributor.authorCastaño Boldú, Esther
dc.contributor.authorFranquesa, Marcella
dc.contributor.authorHerrero Fresneda, Immaculada
dc.contributor.authorTortosa i Moreno, Avelina
dc.contributor.authorRama, Inés
dc.contributor.authorBestard Matamoros, Oriol
dc.contributor.authorGrinyó Boira, Josep M.
dc.contributor.authorLloberas Blanch, Núria
dc.date.accessioned2014-08-01T10:17:36Z
dc.date.available2014-08-01T10:17:36Z
dc.date.issued2009-11-25
dc.date.updated2014-08-01T10:17:36Z
dc.description.abstractP-glycoprotein (Pgp), a protein codified by Multi Drug Resistance (MDR1) gene, has a detoxifying function and might influence the toxicity and pharmacokinetics and pharmacodynamics of drugs. Sampling strategies to improve Pgp studies could be useful to optimize the sensitivity and the reproducibility of efflux assays. This study aimed to compare Pgp expression and efflux activity by measuring Rhodamine123 (Rh123) retention in lymphocytes stored under different conditions, in order to evaluate the potential utility of any of the storing conditions in Pgp functionality. Our results show no change in protein expression of Pgp by confocal studies and Western blotting, nor changes at the mRNA level (qRT-PCR). No differences in Rh123 efflux by Pgp activity assays were found between fresh and frozen lymphocytes after 24 hours of blood extraction, using either of the two Pgp specific inhibitors (VP and PSC833). Different working conditions in the 24 hours post blood extraction do not affect Rh123 efflux. These results allow standardization of Pgp activity measurement in different individuals with different timing of blood sampling and in different geographic areas. _______________
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec576746
dc.identifier.issn1482-1826
dc.identifier.urihttps://hdl.handle.net/2445/56543
dc.language.isoeng
dc.publisherCanadian Society for Pharmaceutical Sciences
dc.relation.isformatofReproducció del document publicat a: http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/6263
dc.relation.ispartofJournal of Pharmacy and Pharmaceutical Sciences, 2009, vol. 12, num. 3, p. 357-366
dc.rightscc-by-sa (c) Chiva Blanch, Gemma et al., 2009
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-sa/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationLimfòcits
dc.subject.classificationGlicoproteïnes
dc.subject.classificationToxicitat dels medicaments
dc.subject.otherLymphocytes
dc.subject.otherGlycoproteins
dc.subject.otherDrug toxicity
dc.titleDifferent Storing and Processing Conditions of Human Lymphocytes do not Alter P-Glycoprotein Rhodamine 123 Efflux
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
576746.pdf
Mida:
659.92 KB
Format:
Adobe Portable Document Format